NASDAQ: NVCR       Novocure Ltd Ord Sh
Last Price Today's Change   Day's Range   Trading Volume
80.09   +2.25 (2.89%)  77.357 - 80.63  1,126,100


Avg Volume (4 weeks):939,594
4 Weeks Range:76.11 - 96.14
4 Weeks Price Volatility (%):
52 Weeks Range:28.83 - 98.70
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

NovoCure Ltd serves in the healthcare sector of United States. Its business involves commercial stage oncology operations involving therapies to cure critical tumors. Its key offering is the TTFields therapy, which is a low-toxicity anti-mitotic treatment that uses low-intensity, intermediate frequency, alternating electric fields to exert physical forces on molecules inside cancer cells, thereby leading to cancer cell death. NovoCure derives its major revenues in the United States, through the sale of TTFields delivery system, which includes a portable electric field generator, transducer arrays, rechargeable batteries, and accessories.

  Be the first to like this.


3995  4101  641  182 

Top 10 Active Counters
 CELG 108.24+0.11 
 EEM 44.42-0.02 
 SPY 317.32+0.19 
 AMD 41.15-1.44 
 VXX 15.53-0.67 
 DHR 148.52-2.78 
 CHK 0.789+0.006 
 FXI 42.60-0.18 
 GE 11.34-0.10 
 BAC 34.44-0.24 
Partners & Brokers